PB 106 of 2014
National Health (Pharmaceutical Benefits – Early Supply) Amendment Instrument 2014 (No. 9) – specification under subsection 84AAA(2)
 
National Health Act 1953
 
I, FELICITY McNEILL, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.
Dated                            19 December 2014
       
     
 
 
 
         
 
                                               
 
 
 
 
FELICITY McNEILL
First Assistant Secretary
Pharmaceutical Benefits Division
Department of Health
 
 
 
___________________________________________________________________________
 
Amendment determination – Pharmaceutical Benefits – Early Supply
 
 
1          Name of Instrument
 
(1)           This Instrument is the National Health (Pharmaceutical Benefits – Early Supply) Amendment Instrument 2014 (No. 9) – specification under subsection 84AAA(2).
 
(2)           This Instrument may also be cited as PB 106 of 2014.
 
2          Commencement
 
This Instrument commences on 1 January 2015.
 
3          Amendment of PB 30 of 2009
 
Schedule 1 amends the National Health (Pharmaceutical Benefits – Early Supply) Instrument 2009 – specification under subsection 84AAA(2) (PB 30 of 2009).
 
 
Schedule 1        Amendments
 
[1]           Schedule 1, after entry for Dutasteride with Tamsulosin
insert:
Empagliflozin
Tablet 10 mg
Oral
30
5
 

 
Tablet 25 mg
Oral
30
5
 

[2]           Schedule 1, after entry for Ezetimibe
insert:
Ezetemibe and rosuvastatin
Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 5 mg (as calcium)
Oral
1
5
 

Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 10 mg (as calcium)
Oral
1
5
 

Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 20 mg (as calcium)
Oral
1
5
 

Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 40 mg (as calcium)
Oral
1
5